On Monday, Privia Health Group Inc (NASDAQ: PRVA) opened higher 4.34% from the last session, before settling in for the closing price of $20.96. Price fluctuations for PRVA have ranged from $15.92 to $24.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 20.87%. Company’s average yearly earnings per share was noted -30.86% at the time writing. With a float of $106.24 million, this company’s outstanding shares have now reached $119.95 million.
The extent of productivity of a business whose workforce counts for 1102 workers is very important to gauge. In terms of profitability, gross margin is 9.47%, operating margin of 0.77%, and the pretax margin is 1.41%.
Privia Health Group Inc (PRVA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Privia Health Group Inc is 11.47%, while institutional ownership is 97.20%. The most recent insider transaction that took place on Sep 10 ’24, was worth 2,500,127. In this transaction Chief Executive Officer of this company sold 135,142 shares at a rate of $18.50, taking the stock ownership to the 247,771 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 135,142 for $18.50, making the entire transaction worth $2,500,719.
Privia Health Group Inc (PRVA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.86% per share during the next fiscal year.
Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators
Check out the current performance indicators for Privia Health Group Inc (PRVA). In the past quarter, the stock posted a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.53. Likewise, its price to free cash flow for the trailing twelve months is 28.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.26 in one year’s time.
Technical Analysis of Privia Health Group Inc (PRVA)
The latest stats from [Privia Health Group Inc, PRVA] show that its last 5-days average volume of 0.59 million was inferior to 0.84 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 51.64%. Additionally, its Average True Range was 0.84.
During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 80.42%, which indicates a significant increase from 73.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.17% in the past 14 days, which was lower than the 42.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.96, while its 200-day Moving Average is $19.00. Now, the first resistance to watch is $22.27. This is followed by the second major resistance level at $22.66. The third major resistance level sits at $23.37. If the price goes on to break the first support level at $21.16, it is likely to go to the next support level at $20.45. The third support level lies at $20.05 if the price breaches the second support level.
Privia Health Group Inc (NASDAQ: PRVA) Key Stats
There are currently 120,001K shares outstanding in the company with a market cap of 2.62 billion. Presently, the company’s annual sales total 1,658 M according to its annual income of 23,080 K. Last quarter, the company’s sales amounted to 437,920 K and its income totaled 3,540 K.
